Clinical Trials Browser

Has results × Vorinostat × Thoracic × Clear all

NCT02638090 2025-12-22

Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Phase 1/2 Active not recruiting

120 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00838929 2025-05-04

Study of the Combination of Vorinostat and Radiation Therapy for the Treatment of Patients With Brain Metastases

Phase 1 Completed

17 enrolled 8 charts

BreastCNSThoracic

Brain Neoplasms, Breast Neoplasms, Lung Neoplasms

NCT00503971 2025-03-07

Phase I/II of Oral Vorinostat Combination With Erlotinib in NSCLC Patients With EGFR Mutations With DP After Erlotinib.

Phase 1/2 Terminated

33 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT00821951 2020-11-20

Vorinostat in Combination With Palliative Radiotherapy for Patients With Non-Small Cell Lung Cancer

Phase 1 Completed

17 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT00128102 2020-10-26

MK-0683-014

Phase 3 Completed

661 enrolled 18 charts

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma

NCT00798720 2019-12-13

Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer

Phase 2 Completed

18 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT00702962 2018-10-22

Carboplatin and Etoposide in Combination With Vorinostat for Patients With Extensive Stage Small Cell Lung Cancer

Phase 1/2 Terminated

8 enrolled 8 charts

Lung Neoplasms, Small Cell Lung Carcinoma

NCT00735826 2018-10-12

A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer

Phase NA Completed

10 enrolled 7 charts

GastrointestinalHead & NeckThoracic

Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms

NCT00138203 2018-01-30

Suberoylanilide Hydroxamic Acid in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Phase 2 Completed

16 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00662311 2017-06-14

Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery

Phase 1/2 Terminated

5 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT00423449 2016-02-04

Clinical Trial of MK0683 in Combination With FDA Approved Cancer Drugs in Patients With Advanced NSCLC (MK0683-058)

Phase 1 Completed

61 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung

NCT00424775 2015-04-20

A Study of Carboplatin + Paclitaxel and MK0683 in Patients With Chemotherapy-naive Non-Small Cell Lung Cancer (NSCLC)(0683-066)

Phase 1 Terminated

3 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00251589 2015-03-06

A Phase I/II Clinical Trial of Vorinostat in Combination With Erlotinib for Patients With Relapsed/Refractory Non-Small-Cell Lung Cancer (0683-025)

Phase 1/2 Terminated

23 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT00481078 2014-10-30

Vorinostat, Carboplatin, and Paclitaxel in Treating Patients With Advanced or Metastatic Non-Small Cell Lung Cancer

Phase 2 Completed

94 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung

NCT00106626 2009-04-22

Suberoylanilide Hydroxamic Acid in Advanced Solid Tumors

Phase 1 Completed

52 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung